Facilitate research to slow progression
- Trial ID
- NCT04496973
- Official Title
- University of Delaware Participant Recruitment Registry for Parkinson's Disease Research
- Goal
- Facilitate research to slow progression
- Status
- RECRUITING
- Sponsor
- University of Delaware
- Study Type
- OBSERVATIONAL
- Enrollment
- 1000 participants
- Conditions
- Parkinson Disease
Plain-Language Summary
The goal is to create a volunteer registry of people with Parkinson's so University of Delaware researchers can quickly find and invite the right participants for future PD studies. Instead of testing a treatment, the registry collects basic health, diagnosis, and contact information and your interest in research, so investigators can match you to appropriate investigator-led studies; it aims to enroll up to 1,000 volunteers. No drugs or devices are given by joining, you are simply agreeing to be contacted about studies you might qualify for. The registry is for adults 21 and older with a clinical diagnosis of Parkinson's who want to be contacted, and it excludes people with non-primary parkinsonism, atypical parkinsonian syndromes, or a clinical diagnosis of dementia.
Locations
- University of Delaware, Newark, Delaware, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to create a volunteer registry of people with Parkinson's so University of Delaware researchers can quickly find and invite the right participants for future PD studies. Instead of testing a treatment, the registry collects basic health, diagnosis, and contact information and your interest in research, so investigators can match you to appropriate investigator-led studies; it aims to enroll up to 1,000 volunteers. No drugs or devices are given by joining, you are simply agreeing to be contacted about studies you might qualify for. The registry is for adults 21 and older with a clinical diagnosis of Parkinson's who want to be contacted, and it excludes people with non-primary parkinsonism, atypical parkinsonian syndromes, or a clinical diagnosis of dementia.
- Who can participate?
- Participants must be between 21 Years and 100 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 9 years and 7 months.